Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial

Renato D. Lópes, Ariane Vieira Scarlatelli Macedo, Pedro Gabriel Melo de Barros e Silva, Renata Moll‐Bernardes, André Feldman, Guilherme Arruda, Andrea Silvestre de Souza, Denílson Campos de Albuquerque, Lilian Mazza, Mayara Fraga Santos, Natalia Salvador, C. Michael Gibson, Christopher B. Granger, John H. Alexander, Olga Ferreira de Souza